Enhanced Ohmyungsamycin A Production via Adenylation Domain Engineering and Optimization of Culture Conditions
Ohmyungsamycins (OMSs) A and B are cyclic depsipeptides produced by marine Streptomyces strains, which are synthesized by a non-ribosomal peptide synthetase. Notably, OMS A exhibits more potent activity against Mycobacterium tuberculosis and human cancer cells than OMS B. The substrate promiscuous a...
Main Authors: | Eunji Kim, Young Eun Du, Yeon Hee Ban, Yern-Hyerk Shin, Dong-Chan Oh, Yeo Joon Yoon |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2021.626881/full |
Similar Items
-
Characterization of the Ohmyungsamycin Biosynthetic Pathway and Generation of Derivatives with Improved Antituberculosis Activity
by: Eunji Kim, et al.
Published: (2019-10-01) -
Structures of teixobactin-producing nonribosomal peptide synthetase condensation and adenylation domains
by: Kemin Tan, et al.
Published: (2020-01-01) -
Discovery of unguisin J, a new cyclic peptide from Aspergillus heteromorphus CBS 117.55, and phylogeny-based bioinformatic analysis of UngA NRPS domains
by: Sharmila Neupane, et al.
Published: (2024-02-01) -
A non-canonical peptide synthetase adenylates 3-methyl-2-oxovaleric acid for auriculamide biosynthesis
by: Daniel Braga, et al.
Published: (2016-12-01) -
Development of a chemical scaffold for inhibiting nonribosomal peptide synthetases in live bacterial cells
by: Fumihiro Ishikawa, et al.
Published: (2024-02-01)